Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction

May 12, 2001·The American Journal of Cardiology·K DöngesUNKNOWN Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) Study Groups

Activation of the hemostatic system during thrombolytic therapy

Dec 16, 1993·The American Journal of Cardiology·P A MerliniP M Mannucci

Combined mechanical and chemical thrombolysis in an experimental animal model: evaluation by angiography and angioscopy

Jan 1, 1990·American Heart Journal·J L RitchieD C Auth

Reperfusion of acute coronary syndromes and myocardial infarction

Sep 30, 2000·Air Medical Journal·J Goltermann

Predictors of success for coronary angioplasty performed for acute myocardial infarction.

Dec 1, 1988·Journal of the American College of Cardiology·S G EllisW W O'Neill

Acute myocardial infarction-related coronary artery residual narrowing after intravenous streptokinase: relationship with previous coronary symptoms

Nov 1, 1989·American Heart Journal·R A SarmientoC A Bertolasi

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

Dec 15, 1990·The American Journal of Cardiology·S D BleichS L Teichman

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate

Aug 1, 1987·The American Journal of Cardiology·M VerstraeteJ Lubsen

Value of negative predischarge exercise testing in identifying patients at low risk after acute myocardial infarction treated by systemic thrombolysis

Jul 1, 1992·The American Journal of Cardiology·G PiccalòC De Vita

Dissimilar systemic and local adverse effects of thrombolytic therapy

Jun 1, 1988·The American Journal of Cardiology·S Sherry

Sudden appearance of coronary thrombus observed by angiography--a case report.

Jan 1, 1991·Angiology·M MoriuchiM Hatano

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

Sep 1, 1993·Circulation·A M Lincoff, E J Topol

Coronary rethrombosis after successful thrombolysis

May 1, 1993·Circulation·V Gurewich

Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation

Jun 1, 1986·Circulation·A J TiefenbrunnB E Sobel

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

Nov 1, 1989·Circulation·S G EllisR M Califf

Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy.

Nov 1, 1989·Circulation·C W White

Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor

Aug 15, 1995·Circulation·D R AbendscheinB E Sobel

Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots

Aug 15, 1995·Circulation·N A PragerP R Eisenberg

Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator

Sep 1, 1988·Circulation·J A JohnsD Collen

❮ Previous

Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction

Abstract

References

Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study

Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction

High dose intravenous streptokinase in acute myocardial infarction

Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies

High-dose, brief intravenous streptokinase early in acute myocardial infarction

Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris

Intravenous short-term infusion of streptokinase in acute myocardial infarction

Sustained improvement in left ventricular function and mortality by intracoronary streptokinase administration during evolving myocardial infarction

Thrombolysis in acute myocardial infarction using intracoronary streptokinase: assessment by thallium-201 scintigraphy

Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction

Intracoronary infusion of streptokinase in patients with acute myocardial infarction: effects of reperfusion on left ventricular performance

Non surgical coronary artery recanalization in acute transmural myocardial infarction

Citations

Coronary stenting for failed angioplasty in acute myocardial infarction

Improving the Efficacy and Stability of Coronary Reperfusion Following Thrombolysis: Exploring the Thrombin Hypothesis

Role of platelet inhibitor therapy in myocardial infarction

Unresolved clinical pharmacologic questions in thrombolytic therapy for acute myocardial infarction

Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction

Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty

Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic study

Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis

Comparison of symptom-limited and low level exercise tolerance tests early after myocardial infarction

Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail

Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial

New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group

Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries

Early T wave inversion after thrombolytic therapy predicts better coronary perfusion: clinical and angiographic study

Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty

Reocclusion: the flip side of coronary thrombolysis

Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity

Continuous ST-segment monitoring during coronary angioplasty using orthogonal ECG leads

Long-term arterial patency after coronary reperfusion

Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis

A cost-effectiveness model for coronary thrombolysis/reperfusion therapy

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

Chronic antithrombotic therapy in post-myocardial infarction patients

Chronic antithrombotic therapy in post-myocardial infarction patients

High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction

Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism

Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction

Appraisal of various thrombolytic agents in the treatment of acute myocardial infarction

Complex stenosis morphology predicts late reocclusion during follow-up after myocardial infarction in patients with patent infarct-related coronary arteries

Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR])

Activation of the hemostatic system during thrombolytic therapy

Combined mechanical and chemical thrombolysis in an experimental animal model: evaluation by angiography and angioscopy

Reperfusion of acute coronary syndromes and myocardial infarction

Predictors of success for coronary angioplasty performed for acute myocardial infarction.

Acute myocardial infarction-related coronary artery residual narrowing after intravenous streptokinase: relationship with previous coronary symptoms

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate

Value of negative predischarge exercise testing in identifying patients at low risk after acute myocardial infarction treated by systemic thrombolysis

Dissimilar systemic and local adverse effects of thrombolytic therapy

Sudden appearance of coronary thrombus observed by angiography--a case report.

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

Coronary rethrombosis after successful thrombolysis

Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulation

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy.

Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor

Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots

Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Related Papers

Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions

Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting "normal" perfusion status, continued arterial patency and survival at one year

Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study

Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator